Pacira Pharma (PCRX) Tops Q2 EPS by 8c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. FIX
9. TSCO
10. BE

Go back to Pacira Pharma (PCRX) Tops Q2 EPS by 8c

Pacira BioSciences Reports Record Revenue of $135.6 Million for the Second Quarter of 2021

August 3, 2021 8:00 AM EDT

-- EXPAREL average daily sales at 178% of the prior year second quarter ---- Conference call today at 8:30 a.m. ET --

PARSIPPANY, N.J., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today reported financial results for the second quarter of 2021.

Second Quarter 2021 Financial Highlights

Total revenues of $135.6 millionGAAP net income of $19.1... More